Andrew G. Shuman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Andrew G. Shuman has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
- Jatin P. Shah
Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, USA
4 shared publications Snehal G. Patel
4 shared publicationsCarol R. Bradford
3 shared publicationsJoseph J. Fins
Weill Cornell Medical College
3 shared publications- Beatriz Korc-Grodzicki
Memorial Sloan Kettering Cancer Center
2 shared publications Erin L. McKean
2 shared publications
Latest Publications
- 1 August 2017
- Published by Elsevier in Otolaryngologic Clinics of North America
- Vol. 50 (4) , 783-792
Decision Making for Diagnosis and Management
- 1 August 2017
- Published by Elsevier in Otolaryngologic Clinics of North America
- Vol. 50 (4) , 783-792
Decision Making for Diagnosis and Management
- 20 May 2016
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 34 (15_suppl) , 6071
Phase II prospective trial of cetuximab and radiotherapy for locally advanced, squamous cell carcinomas of the head and neck in patients >70 years old or with comorbidities not-eligible for platinum-based chemotherapy.
6071 Background: We designed a single arm phase II trial to determine the efficacy and toxicity of concurrent cetuximab (C) radiotherapy (RT) in patients non-eligible for standard chemotherapy. Non-eligibility was defined as age > 70 years (yrs), co-morbidities that preclude platinum-based chemotherapy, or creatinine clearance (CrCl) < 30 mL/min. Primary endpoint was progression free survival. Methods: 22 stage III/IVA patients (pts) were enrolled. The median age was 70 years (range: 40-85), 50% had eGFR with < 90 mL/min, 64% were males, 36% were females; 64% Caucasian, 36 % had an ECOG performance status (PS) of 0, 64% ECOG PS of 1. All pts received C 400 mg/m2 day (d) 0, then 250 mg/m2 d 7 and weekly during RT. Pts were treated with a planned 70 Gray (Gy) in 35 fractions over 7 weeks to the gross tumor and 50-60 Gy to subclinical target volumes.Results: As of January 2016 with a median follow up of 22.8 months and 22 evaluable pts, the median PFS was 30.07 months (95% CI: 2.93, > 50). The overall survival was 33.8 months (95% CI: 9.2, > 50). 6 pts (27%) have recurred, all of whom have died. Treatment related grade 3 toxicities were seen in 7 pts (32%), no grade 4 toxicities were seen. The most common grade 3 toxicities were mucositis (5 pts), dysphagia (4 pts), and dermatitis (3 pts). Conclusions: The results of this phase II prospective study suggest that in patients > 70 yrs old or with comorbidities, precluding platinum-based chemotherapy, tolerate treatment with C+RT well, though survival rates are lesser when compared with historical controls. Clinical trial information: NCT00904345.
- 20 May 2016
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 34 (15_suppl) , 6071
Phase II prospective trial of cetuximab and radiotherapy for locally advanced, squamous cell carcinomas of the head and neck in patients >70 years old or with comorbidities not-eligible for platinum-based chemotherapy.
6071 Background: We designed a single arm phase II trial to determine the efficacy and toxicity of concurrent cetuximab (C) radiotherapy (RT) in patients non-eligible for standard chemotherapy. Non-eligibility was defined as age > 70 years (yrs), co-morbidities that preclude platinum-based chemotherapy, or creatinine clearance (CrCl) < 30 mL/min. Primary endpoint was progression free survival. Methods: 22 stage III/IVA patients (pts) were enrolled. The median age was 70 years (range: 40-85), 50% had eGFR with < 90 mL/min, 64% were males, 36% were females; 64% Caucasian, 36 % had an ECOG performance status (PS) of 0, 64% ECOG PS of 1. All pts received C 400 mg/m2 day (d) 0, then 250 mg/m2 d 7 and weekly during RT. Pts were treated with a planned 70 Gray (Gy) in 35 fractions over 7 weeks to the gross tumor and 50-60 Gy to subclinical target volumes.Results: As of January 2016 with a median follow up of 22.8 months and 22 evaluable pts, the median PFS was 30.07 months (95% CI: 2.93, > 50). The overall survival was 33.8 months (95% CI: 9.2, > 50). 6 pts (27%) have recurred, all of whom have died. Treatment related grade 3 toxicities were seen in 7 pts (32%), no grade 4 toxicities were seen. The most common grade 3 toxicities were mucositis (5 pts), dysphagia (4 pts), and dermatitis (3 pts). Conclusions: The results of this phase II prospective study suggest that in patients > 70 yrs old or with comorbidities, precluding platinum-based chemotherapy, tolerate treatment with C+RT well, though survival rates are lesser when compared with historical controls. Clinical trial information: NCT00904345.
- 1 January 2014
- Vol. 77 (4)
Bleeding by numbers. Rush versus Corbbett.
- 1 January 2014
- Published by Project MUSE in Journal Of Health Care For The Poor and Underserved
- Vol. 25 (4) , 1810-1820
Patching the Safety Net: Establishing a Free Specialty Care Clinic in an Academic Medical Center
We describe the collaboration between an academic medical center and a free primary care clinic that provides multi-specialty services to indigent community members. Complementary components of both institutions have engendered a system in which they broaden the array of available services, providing a prototype for other institutions to collaborate similarly.
- 1 January 2014
- Published by Project MUSE in Journal Of Health Care For The Poor and Underserved
- Vol. 25 (4) , 1810-1820
Patching the Safety Net: Establishing a Free Specialty Care Clinic in an Academic Medical Center
We describe the collaboration between an academic medical center and a free primary care clinic that provides multi-specialty services to indigent community members. Complementary components of both institutions have engendered a system in which they broaden the array of available services, providing a prototype for other institutions to collaborate similarly.
- 1 December 2013
- Published by Elsevier in Oral Oncology
- Vol. 49 (12) , 1136-1140
Outcomes of a head and neck cancer screening clinic
- 1 December 2013
- Published by Elsevier in Oral Oncology
- Vol. 49 (12) , 1136-1140
Outcomes of a head and neck cancer screening clinic
- 10 July 2013
- Published by Wiley in The Laryngoscope
- Vol. 123 (9) , 2142-2147
Implementation of a novel otolaryngology clinic for indigent patients
Objectives/Hypothesis This study was designed to describe the implementation, utilization, and outcomes of an otolaryngology clinic for indigent patients employing a novel design. Study Design Pilot study. Methods A tertiary‐care academic otolaryngology department partnered with a nonprofit outpatient clinic for indigent patients in order to provide free subspecialty consultation services. A novel format was utilized in which the department provided on‐site, scheduled outpatient multidisciplinary consultation on weekends, staffed by volunteer health care providers and ancillary staff. A review of the program was conducted using prospectively collected data. Clinic design, staffing, utilization, and feasibility were described, along with demographic and clinical data for all patients participating in the clinic from October 2010 through January 2012. Results Five clinics were held over 15 months, totaling 74 patient visits, with positive feedback regarding accessibility and quality of services provided. A total of 60 procedures were performed, including audiograms, endoscopies, otologic procedures, biopsies and/or excisions. The estimated value of medical services that were provided was $37,302. Four potentially life‐threatening conditions were newly diagnosed. Twenty patients received conclusive evaluation and treatment at the time of their first visit. Eighteen patients required further subspecialty treatment and/or surgery that could not be provided in the outpatient setting, and were referred appropriately. Conclusions The partnership between an academic otolaryngology department and a nonprofit clinic provided free on‐site consultation for indigent patients. Such an arrangement is feasible, well utilized, and successful in delivering comprehensive specialized services to indigent patients who lack traditional access to medical care. Laryngoscope, 123:2142–2147, 2013
- 10 July 2013
- Published by Wiley in The Laryngoscope
- Vol. 123 (9) , 2142-2147
Implementation of a novel otolaryngology clinic for indigent patients
Objectives/Hypothesis This study was designed to describe the implementation, utilization, and outcomes of an otolaryngology clinic for indigent patients employing a novel design. Study Design Pilot study. Methods A tertiary‐care academic otolaryngology department partnered with a nonprofit outpatient clinic for indigent patients in order to provide free subspecialty consultation services. A novel format was utilized in which the department provided on‐site, scheduled outpatient multidisciplinary consultation on weekends, staffed by volunteer health care providers and ancillary staff. A review of the program was conducted using prospectively collected data. Clinic design, staffing, utilization, and feasibility were described, along with demographic and clinical data for all patients participating in the clinic from October 2010 through January 2012. Results Five clinics were held over 15 months, totaling 74 patient visits, with positive feedback regarding accessibility and quality of services provided. A total of 60 procedures were performed, including audiograms, endoscopies, otologic procedures, biopsies and/or excisions. The estimated value of medical services that were provided was $37,302. Four potentially life‐threatening conditions were newly diagnosed. Twenty patients received conclusive evaluation and treatment at the time of their first visit. Eighteen patients required further subspecialty treatment and/or surgery that could not be provided in the outpatient setting, and were referred appropriately. Conclusions The partnership between an academic otolaryngology department and a nonprofit clinic provided free on‐site consultation for indigent patients. Such an arrangement is feasible, well utilized, and successful in delivering comprehensive specialized services to indigent patients who lack traditional access to medical care. Laryngoscope, 123:2142–2147, 2013
- 27 June 2013
- Published by Wiley in Journal of Surgical Oncology
- Vol. 108 (3) , 187-191
A new care paradigm in geriatric head and neck surgical oncology
Background and Objectives Perioperative management of elderly patients with head and neck cancer poses unique challenges. Our objective is to describe the implementation and feasibility of a novel intervention designed to improve perioperative care in geriatric head and neck surgery. Methods This pilot study was performed in a single‐institution, NCI‐designated comprehensive cancer center. All surgical patients with head and neck cancer over age 75 were offered perioperative consultation with fellowship‐trained geriatricians focusing in geriatric oncology. Results Between 2010 and 2011, a total of 168 patients requiring head and neck surgery were seen by the geriatric service, of which 94% subsequently underwent surgery. Apart from preoperative medical optimization, geriatricians assisted in complex decision‐making regarding the indications for cancer‐directed therapy. Postoperatively, they assisted in preventing and treating delirium and poly‐pharmacy, facilitating discharge planning, and initiating rehabilitation. Postoperatively, 87% were discharged home, and 13% required placement in skilled nursing facilities. At 24 months, overall survival was 80%. Patients, surgeons and geriatricians alike were enthusiastic about the initiative, which is expanding within the institution. Conclusion Geriatric perioperative support for elderly head and neck cancer patients is well‐received with promising potential. The tangible impact and direct benefits of this pilot initiative require additional study. J. Surg. Oncol. 2013; 108:187–191.
- 27 June 2013
- Published by Wiley in Journal of Surgical Oncology
- Vol. 108 (3) , 187-191
A new care paradigm in geriatric head and neck surgical oncology
Background and Objectives Perioperative management of elderly patients with head and neck cancer poses unique challenges. Our objective is to describe the implementation and feasibility of a novel intervention designed to improve perioperative care in geriatric head and neck surgery. Methods This pilot study was performed in a single‐institution, NCI‐designated comprehensive cancer center. All surgical patients with head and neck cancer over age 75 were offered perioperative consultation with fellowship‐trained geriatricians focusing in geriatric oncology. Results Between 2010 and 2011, a total of 168 patients requiring head and neck surgery were seen by the geriatric service, of which 94% subsequently underwent surgery. Apart from preoperative medical optimization, geriatricians assisted in complex decision‐making regarding the indications for cancer‐directed therapy. Postoperatively, they assisted in preventing and treating delirium and poly‐pharmacy, facilitating discharge planning, and initiating rehabilitation. Postoperatively, 87% were discharged home, and 13% required placement in skilled nursing facilities. At 24 months, overall survival was 80%. Patients, surgeons and geriatricians alike were enthusiastic about the initiative, which is expanding within the institution. Conclusion Geriatric perioperative support for elderly head and neck cancer patients is well‐received with promising potential. The tangible impact and direct benefits of this pilot initiative require additional study. J. Surg. Oncol. 2013; 108:187–191.
- 18 April 2013
- Published by Wiley in Head & Neck
- Vol. 36 (5) , 743-749
Optimizing perioperative management of geriatric patients with head and neck cancer
Given emerging demographic trends, many more elderly patients are being diagnosed with head and neck cancers. The surgical care paradigm for this cohort of patients must take into account specific challenges inherent to geriatric perioperative management. This article attempts to summarize the existing body of literature relevant to the geriatric head and neck cancer population, and to extrapolate relevant data from geriatric perioperative medicine in order to better understand and guide management decisions. The involvement of geriatricians and of patients' primary care providers may be invaluable in assisting in complex perioperative decision‐making and in participating in longitudinal management. Preoperative risk stratification and assessment of medical, social, and functional variables are critical for appropriate decision‐making in this challenging patient population. © 2013 Wiley Periodicals, Inc. Head Neck 36: 743–749, 2014
- 18 April 2013
- Published by Wiley in Head & Neck
- Vol. 36 (5) , 743-749
Optimizing perioperative management of geriatric patients with head and neck cancer
Given emerging demographic trends, many more elderly patients are being diagnosed with head and neck cancers. The surgical care paradigm for this cohort of patients must take into account specific challenges inherent to geriatric perioperative management. This article attempts to summarize the existing body of literature relevant to the geriatric head and neck cancer population, and to extrapolate relevant data from geriatric perioperative medicine in order to better understand and guide management decisions. The involvement of geriatricians and of patients' primary care providers may be invaluable in assisting in complex perioperative decision‐making and in participating in longitudinal management. Preoperative risk stratification and assessment of medical, social, and functional variables are critical for appropriate decision‐making in this challenging patient population. © 2013 Wiley Periodicals, Inc. Head Neck 36: 743–749, 2014